Superstring Capital Management »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $907k 26k 35.39
2024-03-31 $5.6M 531k 10.54
2023-12-31 $3.7M 326k 11.23

More positions owned by Superstring Capital Management

Cogent Biosciences (COGT)
Axsome Therapeutics (AXSM)
Genmab A/s Sponsored Ads (GMAB)
Celldex Therapeutics Com New (CLDX)
Trevi Therapeutics (TRVI)
Revolution Medicines (RVMD)
Definium Therapeutics Com Shs (DFTX)
Vir Biotechnology (VIR)
Immunovant (IMVT)
Urogen Pharma (URGN)
Eliem Therapeutics (CLYM)
Adlai Nortye Sponsored Ads (ANL)
Savara (SVRA)
Maplight Therapeutics (MPLT)
Oric Pharmaceuticals (ORIC)

View all positions for Superstring Capital Management

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

FMR
Morgan Stanley
BlackRock
QVT Financial
Vanguard Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
UBS Group
State Street Corporation
Farallon Capital Management
Geode Capital Management
Adage Capital Partners GP
Two Seas Capital
Wells Fargo & Company
Assenagon Asset Management

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017